Newsfiscal.ai
Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at ICAR 2026
· Published
Article summary
Larimar Therapeutics will present new clinical data and analyses regarding its lead candidate, nomlabofusp, at the International Congress for Ataxia Research (ICAR) 2026.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…